preceptors 3
preceptors 4

Preceptors are listed by their primary area of practice. Most resident programs will interact with preceptors from multiple areas. 

Rachael Prusi, PharmD, MSGH​

Director, Graduate Pharmacy Education

Clinical Manager of Graduate and Undergraduate Education

 

Rotations:

Pharmacy Administration

Education:

PharmD: Ferris State University

Residency:

PGY1: Southern Arizona VA Health Care System

Practice Interests:

Pharmacy education, continuing professional development, cardiology, medication safety

Professional Organization Affiliation and Leadership:

ASHP (Member of Section of Pharmacy Practice Managers – Advisory Group on Leadership Development; Previously Section of Inpatient Practitioners – Advisory Group on Pharmacy Practice Education[2011-2016])

Publications: 

  • Phatak, A., Prusi, R., Ward, B., Hansen, L. O., Williams, M. V., Vetter, E., ... & Postelnick, M. (2016). Impact of pharmacist involvement in the transitional care of high‐risk patients through medication reconciliation, medication education, and postdischarge call‐backs (IPITCH Study). Journal of hospital medicine, 11(1), 39-44.

  • McLaughlin, M. M., Short, E., Prusi, R., Masic, D., Chapman, N. R., & Postelnick, M. (2017). Implementation of a pharmacy research committee to enhance the pharmacy resident research experience. Currents in Pharmacy Teaching and Learning, 9(6), 1141-1146.

  • “Preceptor Pearl: A Team Approach to Precepting”. Midwestern University College of Pharmacy Newsletter Teaching Tomorrow’s Pharmacists. Winter 2014.

Academic and/or National Presentations:  

  • “Impact of Pharmacist Involvement in the Transitional Care of High-Risk Patients through Medication Reconciliation, Medication Education and Post-Discharge Callbacks” United Health Care Consortium, Las Vegas, NV. October 2014.

  • “Teaching Pearls” ASHP National Pharmacy Preceptors Conference, Washington, DC. 2014.

  • Northwestern University, Physician Assistant College, Chicago, Illinois. Pharmacology Lectures:

    • “Hyperlipidemia treatment” 2011-2015

    • “Hypothyroidism, hyperthyroidism, Grave’s Disease” – 2010-2015

    • “Genitourinary Tract Infections” 2011-2015

    • “Skin and soft tissue infections, psoriasis, dermatitis, eczema and other skin disorders” 2012.

  • “Pharmacologic pain management and supportive care in multiple sclerosis” 8th Annual Neuroscience Nursing Symposium, Northwestern University. Chicago, Illinois. 2011.

  • “Update on diabetes literature” Continuing education lecture. Arizona Health Sciences Academy. Mesa, Arizona. 2009.

Health-System Administration

 

Anthony (Tony) Scott, PharmD

Director, PGY1/2/MS Health System Pharmacy Administration Residency

Assistant Director of Pharmacy Operations

 

Rotations:

Advanced Pharmacy Operations

Education:

PharmD: The University of Georgia

Residency:

PGY1- Pharmacy Practice: Piedmont Hospital

PGY2- Administration: North Florida South Georgia VA Hospital

Practice Interests:

Administration

Professional Organization Affiliation and Leadership:

ASHP, Section Advisory Group on Leadership Development. ICHP, Professional Affairs

Academic and/or National Presentations:

  • Scott A, Gomes E. Assessing pharmacist productivity using an operations dashboard in an academic medical center. Poster presented at the American Society of Health-System Pharmacists Summer Meeting, Denver CO, June 2018.

  • Scott A, Bastow S, Knoebel R. Radio frequency identification tags to improve accuracy of anesthesia medication trays in the procedural setting. Poster presented at the 13th Annual UCM Quality & Safety Symposium. Chicago, IL. May 2018

  • Scott A, Colgan K, Allen L, Mota L. The optimization of automated dispensing cabinets in an academic medical center. Poster presented at the Illinois Council of Health-System Pharmacists Spring Meeting, Collinsville, IL, April 2017.  

  • “The First 30-90 Days.” Presented nationally broadcasted Vizient web seminar coordinated with professional development pharmacy leaders. June 2018. ACPE-accredited CE program.

  • “ASHP Pharmacy Student Forecast Workshop.” Coordinated and presented a 4 hour workshop at Midwestern University  for Illinois and Wisconsin pharmacy students with the UCM leadership team to promote student awareness or emerging trends in healthcare and opportunities within pharmacy practice. March 2018.

  • “The future is now: Developing tomorrow’s pharmacy leaders today.” American Society of Heath-System Pharmacists Midyear Clinical Meeting & Exhibition. Orlando, FL. December 2017. ACPE-accredited CE program.

  • “Optimizing medication distribution using automated dispensing cabinets.” Illinois Council of Health-System Pharmacists Annual Meeting. Oakbrook Terrace, IL. September 2017. ACPE-accredited CE program.

Current Research: Technology and Automation Optimization, Operational Excellence

Bryan McCarthy, PharmD, MS, BCPS

Coordinator, PGY1/2/MS Health System Pharmacy Administration Residency

Director, Adult Inpatient Pharmacy Services

 

Rotations:

Pharmacy Administration and Leadership, Senior Pharmacy Leadership

Education:

PharmD: University of Rhode Island

Residency:

PGY1/2 Health System Pharmacy Administration: Hennepin County Medical Center

Practice Interests:

Leadership, Business Development, Medication Safety

Professional Organization Affiliation and Leadership: 

ASHP Section of Pharmacy Practice Managers - Section Advisory Group on Management of the Pharmacy Enterprise, AJHP Editorial Board, ICHP New Practitioners Forum Chair

Publications:  https://www.ncbi.nlm.nih.gov/pubmed/?term=bryan+mccarthyhttps://www.ncbi.nlm.nih.gov/pubmed/?term=bryan+mccarthy 

Academic and/or National Presentations: 

  • Gauen K, McCarthy BC Jr. “Take Back the Narcs! Implementing a Medication Disposal Kiosk.” Presentation at the 2018 ICHP Spring Meeting; 2018 Apr 13; East Peoria, IL. • Farano J, Corsi M, Stahle S, McCarthy BC Jr. “ASHP Pharmacy Forecast.” Presentation and case facilitation at the 2018 ASHP Pharmacy Forecast Student Workshop; 2018 Mar 24; Downers Grove, IL.

  • McCarthy BC Jr. "Publishing Administrative Pharmacy Literature". Pharmacy Administrative Resident Coalition webinar presentation using WebEx; 2018 Mar 7; Online.

  • McCarthy BC Jr. Leadership Workshop. Guest lecture provided in PHAR6223 PHAR 6223, Professional Practice III-Institutional Orientation course at Chicago State University College of Pharmacy; 2018 Jan 4; Chicago, IL. • McCarthy BC Jr. “A-B-C’s and 1-2-3’s of the M2B Business Plan.” Presentation at the 2017 ASHP Midyear Clinical Meeting; 2017 Dec 5; Orlando, FL.

  • McCarthy BC Jr. “Hitting a moving USP <800> target in practice.” Presentation at the 2016 Vizient Pharmacy Network Meeting; 2016 Dec 3; Las Vegas, NV. • McCarthy BC Jr. Quality, Risk Management and Compliance. Guest lecture provided in PHAR6321 Pharmacy Practice Management course at Chicago State University College of Pharmacy; 2016 Sep 12-13; Chicago, IL.

  • McCarthy BC Jr. Distinguished Practitioner Panel. Panel presentation at the 2016 ICHP Student Leadership Retreat; 2016 Sep 10; Chicago, IL. 

Current Research:  Examining the Post-Crash Wreckage: Finding the What, Why, and How Behind Medication Error.

Russell (Jason) Orr, PharmD, MBA

Executive Director, Inpatient Pharmacy Services 
Director of Pharmacy, Comer Children's Hospital

 

Rotations:

Senior Pharmacy Leadership, Pediatric Pharmacy Administration

Education:

PharmD: University of Houston College of Pharmacy

-MBA: National Louis University
-Six Signa Master: Villanova University 

Residency:

PGY1: Children's Healthcare of Atlanta (Egleston and Scottish Rice Campuses)

Practice Interests:

Leadership, Pediatrics,  Medication Safety, USP 800, Lean Modeling, Choice Architecture, Strategy, Outcomes, Continual Process Improvement   

Kevin Colgan, MA, FASHP

Vice President, Chief Pharmacy Officer

 

Rotations:

Senior Pharmacy Leadership

Pharmacy Administration

Education:

BS Pharmacy: St. Louis College of Pharmacy

Responsibilities:

Chairman, Board of Trustees - St. Louis College of Pharmacy

Board of Pharmaceutical Specialties Employer Advisory Committee

Practice Interests:

Administration, Specialty Pharmacy, Outcomes Research

Denise Scarpelli, PharmD

Executive Director, Ambulatory Pharmacy Business and Development

 

Rotations:

Executive Ambulatory Pharmacy Administration

Education:

PharmD: University of Illinois at Chicago

Practice Interests:

Ambulatory Pharmacy

Professional Association Affiliation and Leadership:

  • ASHP: vice-chair of the SAG committee on business development for specialty

  • Illinois Board of Pharmacy: vice-chair 
     

Charlene Hope, PharmD, MS, BCPS, CPPS

Chief Pharmacy Quality and Safety Officer

 

Rotations:

Pharmacy Quality and Medication Safety

Quality Improvement

Education:

PharmD: Midwestern University

Residency:

PGY1: Michael Reese Hospital, Chicago, IL

Practice Interests:

Quality Improvement, Healthcare Quality, Patient Safety

 

PGY2 Informatics

Seth Hartman, PharmD, MBA

Director, PGY2 Pharmacy Informatics Residency

Director of Pharmacy Informatics

 

Rotations:

Pharmacy Informatics Leadership

Education:

PharmD: University of  Missouri Kansas City

Practice Interests:

Quality, Safety, and efficiency of patient care

Professional Association Affiliation and Leadership:

  • HIMSS member since 2010

  • ASHP Director-at-Large for the Section of Pharmacy Informatics and Technology

  • ASHP Faculty for the Pharmacy Informatics Certificate Program

  • MATTER for healthcare startups mentor

Publications:

  • Development and implementation of an electronic health record based medication reconciliation risk stratification tool to optimally deploy limited pharmacy resources [abstract]- Presented at Society of Hospital Medicine conference - Hospital Medicine 2018 in Orlando, FL

  • Recommendations to Improve the Usability of Drug-Drug Interaction Clinical Decision Support Alerts Published in the Journal of the American Medical Informatics Association J Am Med Inform Assoc 2015;0:1–10. doi:10.1093/jamia/ocv011

Maggie Wong, PharmD, BCPS

Coordinator, PGY2 Pharmacy Informatics Residency

Informatics Pharmacist Specialist

 

Rotations:

Ambulatory Informatics

Education:

PharmD: Midwestern University - Chicago College of Pharmacy

Residency:

PGY1 - HSHS St. Elizabeth's Hospital

PGY2 Informatics - Hospital Sisters Health System

Practice Interests:

Medication safety, clinical decision support, workflow optimization

Michael Wall, PharmD, MBA

Chief Analytics Officer

 

Rotations:

Advanced Data Analytics

Education:

Graduate School of Business, School of Nursing, Stritch School of Medicine, and the School of Law

Loyola University Chicago, Chicago, Illinois

 

Fellowship in Pharmacoeconomics and Health Outcomes Research

School of Public Health, Health Management and Policy

University of Michigan, Ann Arbor, Michigan

Pfizer, Ann Arbor, New York

 

Doctor of Pharmacy, Honors

Butler University, Indianapolis, Indiana

Practice Interests:

Data & analytics

Recent Publications:

  • Wall MJ, Dudas JM. Data in healthcare: Where it comes from, how it's structured, how to govern it, and how to get your hands on it. Healthcare Delivery Science Book Chapter [in development].

  • Stevens, JP, Wall MJ, Novack L, Marshall J, Hsu DJ, Howell MD. The critical care crisis of opioid overdoses in the United States. Annals of the American Thoracic Society 14(12), pp. 1803–1809, Dec 2017.

  • Wall, MJ. (2017, Aug 15). Phone interview and article with K Thometz from WTTW Chicago Tonight. Study: Cost, Severity of Opioid Overdose Admissions to ICU Rising

 

PGY1 Residency Director and Coordinators

Randall Knoebel, PharmD, BCOP

Director, PGY1 Pharmacy Residency

Senior Manager, Pharmacy Health Analytics & Drug Policy

Director, Pain Stewardship Pharmacy

 

Rotations:

High Reliability/Formulary Management

Education:

PharmD: Midwestern University Chicago

MPH (in process) – University of Illinois, Chicago

Residency:

PGY1: Rush University Medical Center

PGY2 Hematology/Oncology: University of Washington

Practice Interests:

Pain management, Pharmacogenomics, Implementation Science, Quality Improvement, Data/Analytics

Professional Organization Affiliation and Leadership:

          ACCP, ICHPVizient

Publications:

          https://scholar.google.com/citations?user=dsBNX-oAAAAJ&hl=en&oi=ao

Academic and/or National Presentations

  • “Stewardship Realized: Application of High-Reliability Principles to Achieve High Quality Pain Care” – Midwest Pain Society 43rd Scientific Meeting: Chicago, IL. September, 2019

  • “Key Thoughts on Controlling Pharmacy Spend for Hospitals” - Becker’s Healthcare: Chicago, IL. February, 2019

  • “Through the Looking Glass – Transforming Benchmarking Data into Clinically Actionable Strategies” – Vizient Annual Meeting: Anaheim, CA. November, 2018

  • “High Reliability: Find Out What it Means to Me” – Pharmacy Grand Rounds: Chicago, IL. November, 2018

  • “PK & PD Alterations in Elderly: Implications in Opioid Prescribing” – Regional Palliative Care Fellow Conference: Chicago, IL. October, 2018 

  • “Pain Stewardship: Implementing an Institutional Approach to Pain Management” - Illinois Council of Health-System Pharmacists: 2017 Annual Meeting: Oak Brook, IL. September, 2017

  • “Role of Patient Education Amidst the Opioid Epidemic” - Patient and Family Advisory Council for Heart and Vascular Services: Chicago, IL. May, 2017

  • “Perils and Pearls When Prescribing – Speed Dating with a PharmD” - The Coleman Palliative Medicine Training Program ; Winter 2016 Palliative Medicine Conference. February, 2016

Current Research:

  • Kerins A, Knoebel RW, Dickerson DM, Anitescu M. Optimizing institutional care of implantable intrathecal drug delivery systems. 

  • Knoebel RW, Miller P. Disparities Among African Americans and their Influence on Chronic Pain Management. 

  • Derman BA, Streck M, Wynne J, Curran E, Stock W, Knoebel RW. Efficacy and Toxicity of Reduced vs. Standard Dose Pegylated Asparaginase in Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia. 

  • Truong T, Apfelbaum J, Shahul S, Anitescu M, Danahey K, Knoebel RW, Liebovitz D, Karrison T, van Wijk X, Yeo KT, Meltzer D, Ratain M, O’Donnell P. The ImPreSS Trial: Implementation of Point-of-Care Pharmacogenomic Decision Support in Perioperative Care.

  • Corsi M, McCarthy B, Knoebel RW, Fahrenbach J, O’Connor M, Davis A, Hartman S, Stull A, Wall M. Examining the Post-Crash Wreckage: Finding the What, Why, and How Behind Medication Error.

  • Prachand V, Dickerson D, Bonacorsi M, Wiora L, Knoebel RW. Results of a Novel Reduction and Return of Opioids After Surgery (ROPAS) Program: Over One Ton of Unused Medication Returned for Disposal.

Patrick Costello, PharmD, BCCCP

PGY1 Pharmacy Residency Program Coordinator

Clinical Pharmacist Specialist - Critical Care

 

Rotations:

Medical Intensive Care Unit, Advanced Medical Intensive Care Unit

Education:

PharmD: University of Illinois at Chicago

Residency:

PGY1: University of Chicago Medicine

PGY2 Critical Care: University of Chicago Medicine

 Practice Interests:

Emergency response, shock states, hemodynamics, pharmacokinetic and pharmacodynamic alterations in the critically ill

Professional Organization Affiliation and Leadership: SCCM, ASHP, ICHP

Current Research:

  • Evaluation of stress ulcer prophylaxis versus no stress ulcer prophylaxis in the medical intensive care unit

  • Hydrocortisone and fludrocortisone versus hydrocortisone for septic shock

  • Evaluation of angiotensin II in the treatment of shock in the intensive care units

Hailey Soni, PharmD, BCPS

PGY1 Pharmacy Residency Program Coordinator

Clinical Coordinator - Internal Medicine

Clinical Pharmacy Specialist - Internal Medicine

 

Rotations:

Internal Medicine, PGY1 Leadership

Education:

PharmD: University of Wisconsin-Madison

Residency:

PGY1: Ministry Saint Joseph's Hospital

Practice Interests:

Anticoagulation, chronic kidney disease, diabetes management, parenteral nutrition, liver disease

Professional Organization Affiliation and Leadership:

  • Vizient- Quality, Safety and Compliance Committee Member

  • ICHP- Educational Affairs Division Committee Member

  • ACCP- general member

  • ASHP- general member

Academic and/or National Presentations:

  • Creating a Culture of Resident Well-being- Jennifer Austin-Szwak, PharmD, BCPS, Hailey P Soni, PharmD, BCPS. American Society of Health-System Pharmacists (ASHP)- National Pharmacy Preceptors Conference (NPPC)

Current Research: 

  • Impact of Psychological Debriefing on the Mental Health of Pharmacy Residents Participating in a 24-hour, In-House Clinical Pharmacy On-Call Program- Kevin Mercer, PharmD, Kaitlyn Craddock, PharmD, Sajni Patel, PharmD, BCPS, Samantha Bastow, PharmD, BCPS, Randall Knoebel, PharmD, BCOP, Hailey P. Soni, PharmD, BCPS, Laura Lourenco, PharmD, BCPS, Jennifer Austin-Szwak, PharmD, BCPS

  • The Efficacy of Ketamine versus Lidocaine Infusions as Adjunctive Treatment of Acute Pain in Hospitalized Sickle Cell Disease Patients. Nicolas Zalava, Hailey P. Soni, PharmD, BCPS, Jennifer Austin, PharmD, BCPS, Randall Knoebel, PharmD, BCOP, Magda Anitescu, MD

Cardiology

 

Sajni Patel, PharmD, BCPS

Director, PGY2 Cardiology Pharmacy Residency

Clinical Pharmacy Specialist - Cardiology

 

Rotations:

Cardiac Intensive Care Unit

Education:

PharmD: Northeastern University

Residency:

PGY1: Boston Medical Center

PGY2 Cardiology: The Ohio State University Wexner Medical Center

Practice Interests:

Cardiology, Research, Teaching

Professional Organization Affiliation and Leadership

  • American College of Cardiology, member of the Cardiovascular Team Section

  • American Society of Health System Pharmacists

Publications

  • Lat I, Patel S. Shock Syndromes. In Erstad B. Critical Care Pharmacotherapy. Lenexa, KS: American College of Clinical Pharmacy; 2015: 410-437.

Academic and/or National Presentations​

  • Association between cumulative pre-transplant amiodarone dose and post-transplant outcomes after heart transplantation- Vizient Pharmacy Poster Session in conjunction with American Society of Health System Pharmacists, Anaheim, CA December 2018

  • Impact of a national drug shortage of dobutamine on hospital readmission for acute decompensated heart failure- Vizient Pharmacy Poster Session in conjunction with American Society of Health System Pharmacists, Anaheim, CA December 2018

  • Impact of psychological debriefing on the mental health of pharmacy residents participating in a 24-hour, in house clinical pharmacy on-call program- The Illinois Council of Health-System Pharmacists Annual meeting, Oakbrook Terrace, IL April 2018

  • Safety of erythropoietin in Jehovah’s Witness patients undergoing cardiac surgery- The American College of Cardiology Cardiovascular Team Poster session, The American College of Cardiology Annual Scientific Meeting, Orlando, FL March 2018

  • Adverse effects of inappropriately prescribed direct oral anticoagulants- Vizient Pharmacy Poster Session in conjunction with American Society of Health System Pharmacists, Orlando, FL December 2017

  • Adverse effects of inappropriately prescribed direct oral anticoagulants- Vizient Pharmacy Poster Session in conjunction with American Society of Health System Pharmacists, Las Vegas, NV December 2016

  • Medication fill history as a surrogate for heart failure readmission- University Hospital Consortium in conjunction with American Society of Health System Pharmacists, New Orleans, LA December 2015

  • Acute decompensated heart failure pathway to reduce readmissions- The University of Chicago Medicine Annual Quality and Safety Symposium, Chicago, IL May 2015

  • Argatroban dosage requirements in critically ill patients with Heart Failure- The American College of Cardiology Cardiovascular Team Poster session, The American College of Cardiology Annual Scientific Meeting, San Diego, CA March 2015

  • Anticoagulation indices in extracorporeal membrane oxygenation patients- The Society of Critical Care Medicine Annual Clinical Meeting, Phoenix, AZ January 2015

  • Nesiritide prolongs hospital length of stay in patients with heart failure with a preserved ejection fraction- The Heart Failure Society of America Annual Clinical Meeting, Orlando, FL September 2013

  • Effect of nesiritide on patients with heart failure with preserved ejection fraction- University Hospital Consortium in conjunction with American Society of Health System Pharmacists, Las Vegas, NV December 2012

  • Quality improvement initiative to decrease time to antibiotic administration in patients with sepsis- American Thoracic Society, San Francisco, CA May 2012

  • Quality improvement initiative to decrease time to antibiotic administration in patients with sepsis- University Hospital Consortium in conjunction with American Society of Health System Pharmacists, New Orleans, LA December 2011

Current Research

  • Impact of the dobutamine national drug shortage on hospital length of stay in patients admitted with acute decompensated heart failure

  • Association between cumulative pre-transplant amiodarone dose and post-transplant outcomes after heart transplantation

Pamela Simone, PharmD, BCCP

Clinical Pharmacy Specialist - Cardiology

Rotations:

Cardiology, Cardiac Surgery

Education:

PharmD: Midwestern University Chicago College of Pharmacy

Residency:

PGY1 & PGY2 Cardiology: University of Chicago Medicine

 Practice Interests:

Mechanical circulatory support, advanced heart failure, electrophysiology

Professional Organization Affiliation and Leadership:

American College of Cardiology: member of the Cardiovascular Team Section

Publications:

  • Minner SA,Simone P, Chung BB, Shah AS. Successful reversal of bradycardia and dyspnea with aminophylline after ticagrelor load. J Pharm Pract. 2016 Dec. COI 10.1177/089710016680978

  • Ader PB, Benken S, Patel S, Tung A. Anticoagulation indices in adult extracorporal membrane oxygenation patients. Crit Care Med. 2014;42(12):A160.Abstract  

  • Arif SA, Drury R, Ader P.Impact of Food and Drug Aministration hepatotoxicity warning on prescribing and monitoring of dronedarone in a tertiary teaching hospital. Int J Pharm Pract. 2015. Doi: 10.1111/ijpp. 12217

Academic and/or National Presentations:

  • Opioid Use in LVAD Patients is Associated with Increased GI Bleed and Sepsis - International Society of Heart and Lung Transplant, Orlando, FL April 2019

  • Association Between Cumulative Pre- Transplant Amiodarone Dose and Post- Transplant Outcomes After Heart Transplant - International Society of Heart and Lung Transplant, Orlando, FL April 2019

  • Evaluation of Impact of Heparin Protocol in Ventricular Assist Device Patients Inappropriate dosing of direct oral anticoagulants and associated complications - American College of Cardiology, Pharmacist Poster Session, New Orleans, LA March 2019

  • Adverse effects of inappropriately prescribed direct oral anticoagulants- Vizient Pharmacy Poster Session in conjunction with American Society of Health System Pharmacists, Orlando, FL December 2017

  • Adverse effects of inappropriately prescribed direct oral anticoagulants- Vizient Pharmacy Poster Session in conjunction with American Society of Health System Pharmacists, Las Vegas, NV December 2016

  • Medication fill history as a surrogate for heart failure readmission- University Hospital Consortium in conjunction with American Society of Health System Pharmacists, New Orleans, LA December 2015

  • Anticoagulation indices for Impella patients University Hospital Consortium in conjunction with American Society of Health System Pharmacists, New Orleans, LA December 2015

Current Research:

  • Amiodarone versus digoxin for initial rate control for atrial fibrillation in critically ill patients

  • Impact of aspirin dosing on thrombotic outcomes in patients with the HVAD

Critical Care and Emergency Medicine

 

Sarah Sokol, PharmD, BCPS, BCCCP

Director, PGY2 Emergency Medicine Pharmacy Residency

Director, PGY2 Critical Care Pharmacy Residency

Clinical Pharmacy Specialist – Critical Care

Rotations:

Medical ICU

Education:

PharmD: Texas A&M University and University of Houston

Residency:

PGY1: University of Chicago Medicine

PGY2 Critical Care: University of Chicago Medicine

PGY3 Critical Care Research Fellow: University of Chicago Medicine

 Practice Interests:

Septic shock and vasoactives, sedation and delirium, ARDS

Dan Fischer, PharmD

Coordinator, PGY2 Emergency Medicine Pharmacy Residency

Rotations:

Emergency Medicine

Education:

PharmD: Oregon State University College of Pharmacy

Residency:

PGY1: Intermountain Medical Center Murray, UT

PGY2 Emergency Medicine: University of Colorado Hospital Aurora

 Practice Interests:

ACLS, Toxicology, Neurology

Recent Peer-Reviewed Publications:

  • Fischer D, et al. Three- vs Four-Factor Prothrombin Complex Concentrate in Warfarin-Associated Intracranial Hemorrhage. Neurocritical Care. 2017

Heather Bullard, PharmD, BCCCP

Clinical Pharmacist Specialist - Cardiothoracic Surgery

Full Member, The Institutional Review Board, Division of Biological Sciences 

Rotations:

Cardiothoracic ICU, Medical Research & Writing

Education:

PharmD: Ferris State University

Residency:

PGY1: Spectrum Health

PGY2 Critical Care: Cleveland Clinic

 Practice Interests:

Mechanical circulatory support, anticoagulation, outcomes based research, disaster preparedness and response

Recent Peer-Reviewed Publications:

  • Lat I, Daley MJ, Shewale A, et al on behalf of the DEFINE study group and the Discovery Research Network (Acknowledgement: Bullard HM) A Multicenter, Prospective, Observational Study to Determine Predictive Factors for Multidrug-Resistant Pneumonia in Critically Ill Adults: The DEFINE Study. Pharmacotherapy. 2019;39(3):253-260. doi: 10.1002/phar.2171

  • Shumaker AC, Bullard HM, Churpek J, Knoebel R. Posaconazole-Digoxin Drug-Drug Interaction Mediated by Inhibition of P-glycoprotein. J Oncol Pharm Practice. https://doi.org/10.1177/1078155218801055.

  • Davidson JE, Aslakson RA, Long AC. (Acknowledgement: Bullard HM) Guidelines for Family-Centered Care in the Neonatal, Pediatric, and Adult ICU. Crit Care Med. 2017 Jan; 45(1):103-128. 

  • Steward JS, Bullard HM, O’Rourke TJ, Campbell AD, Brinker BT, Yost KJ, Vanderwoude AC, Scott WL, Kintzel PE. Effect of Single Agent High-Dose Methotrexate-Related Acute Kidney Injury on Length of Hospitalization and Relative Dose Intensity in Adult Patients with Central Nervous System Lymphoma. J Oncol Pharm Practice. 2017 Oct; 23(7):496-501. 

  • Devlin, JW, Michaud CJ, Bullard HM, Harris SA, Thomas WL. Quetiapine for Intensive Care Unit Delirium: The Evidence Remains Weak. Pharmacotherapy. 2016 Feb; 36(2):e12-4.

  • Michaud CJ, Bullard HM, Harris SA, Thomas WL. Impact of Quetiapine Treatment on Duration of Hypoactive Delirium in Critically Ill Adults: a Retrospective Analysis. Pharmacotherapy 2015 Aug; 35(8):731-9.

  • Bockheim HM, Harris SA, Kirschner Z, McAllen K, Michaud CJ, Rivard B, Thomas W, VandenBerg M, authors. Barletta JF, original contributor. Kirschner Z, Michaud CJ, editors. Dores N, Hauck J, Prospal D, Gurka M, Zechmeister C, Belfer J, additional contributors. Adult Critical Care Clinical Pharmacy Handbook: Guidelines, Algorithms, and Clinical Pearls. Self-Published and Circulated. 2014 Dec. Pages 1-155.

  • Kane-Gill SL, LeBlanc JM, Dasta JF, Devabhakthuni S. A multicenter study of the point prevalence of drug-induced hypotension in the ICU; Critical Care Pharmacotherapy Trials Network. Crit Care Med. 2014 Oct; 42(10):2197-203.

  • Michaud CJ, Bockheim HM, Nabeel M, Daum T. Diagnosis of Exclusion: A Case Report of Probable Glatiramer Acetate-Induced Eosinophilic Myocarditis. Case Rep Neurol Med. 2014:786342. doi: 10.1155/2014/786342. Epub 2014 Jul 3.

  • Bockheim HM, McAllen KJ, Baker R, Barletta JF.  Mechanical Prophylaxis to Prevent Venous Thromboembolism in Surgical Patients: A Prospective Trial Evaluating Compliance.  Journal of Critical Care (2009) 24, 192-196.

Recent Academic and National Presentations:

  • Anemia in Critical Illness – Beyond Transfusion. Iron Supplements – Indications and Administration.  Presented as part of the 47th Annual Critical Care Congress.  Society of Critical Care Medicine.  San Antonio, Texas.  February 2018.

  • The Rise of The Machines: VADs, IABP, Impella. Presented as part of the Chicagoland Critical Care Conference. Chicago, Illinois. August 2016.  

  • The Role of the Critical Care Pharmacist in Disaster Preparedness.  Presented as part of the 40th Annual Critical Care Congress.  Clinical Pharmacy and Pharmacology Pre-Congress Symposium.  Society of Critical Care Medicine.  San Diego, California.  January 2011.

  • Year in Review Pharmacy: Cardiac Critical Care.  Presented as part of the 39th Annual Critical Care Congress.  Society of Critical Care Medicine.  Miami, Florida.  January 2010.

Professional Organization Affiliation and Leadership:

  • Society of Critical Care Medicine, CPP Section, Practice Advancement Committee

  • Society of Critical Care Medicine, Research Section, Awards Committee

  • Society of Critical Care Medicine, CPP Section, Program Committee Past Chair

  • Society of Critical Care Medicine, Patient and Family Support Committee, Past Member

  • Society of Critical Care Medicine, Fundamentals of Disaster Management Committee, Past Member  

  • Kent County Medical Reserve Corps, Board of Directors, 2007-2014

  • American College of Clinical Pharmacy, Member

  • American Society of Health Systems Pharmacists, Member

Mary Kate Miller, PharmD, BCPS, BCCCP

Clinical Pharmacy Coordinator, Surgery

Clinical Pharmacist Specialist - Critical Care

Rotations:

Surgical-Trauma ICU, Burn ICU

Education:

PharmD: Chicago State University

Residency:

PGY1 & PGY2 Critical Care: University of Chicago Medicine

 Practice Interests:

Shock states, acute burn and trauma resuscitation, disaster preparedness, infectious diseases, pain management

Professional Organization Affiliation and Leadership:

Society of Critical Care Medicine
American Burn Association
Illinois Council of Health-System Pharmacist

Academic and/or National Presentations:

  • Pharmacology in Burn Patients. Chicago Burn Disaster Training Course. Chicago, IL. April 2018.

  • Teaching Two Old Drugs New Tricks: The Use of Lidocaine and Ketamine For Analgesia in the OR and ER for Non-Opioid Pain Management. ICHP Spring Meeting. Peoria, IL. April 2018

  • Efficacy of low-dose ketamine infusion for adjunctive analgesia in acute burn patients. American Burn Association Annual Meeting. Boston, MA. March 2017

  • Pharmacology in Burn Patients. Illinois Burn Disaster Training Course. Chicago, IL. April 2016

  • Effectiveness and safety of enoxaparin prophylaxis dosed by a predictive equation in acute burn patients. Society of Critical Care Medicine Annual Congress. Phoenix, AZ. Feb 2015

Current Research:

  • Pharmacologic considerations in the management of acute burn patients receiving mechanical circulatory support

Olabisi Falana, PharmD, BCPS

Clinical Pharmacy Specialist - Neurocritical Care

Rotations:

NeuroICU

Education:

PharmD: University of Wisconsin - Madison

Residency:

PGY1: Rush University Medical Center

PGY2 Critical Care: Rush University Medical Center/Midwestern University Chicago

 Practice Interests:

Refractory status epilepticus, intraventricular/intrathecal drug administration, subarachnoid hemorrhage, cerebral vasospasm, septic shock, neuroendocrine, ICP hypertension, traumatic brain injury, international pharmacy practice

Laura Celmins, PharmD, BCPS, BCCCP

Clinical Pharmacy Specialist - Emergency Medicine

Rotations:

Adult/Pediatric Emergency Medicine

Education:

PharmD: The University of New Mexico

Residency:

PGY1: Cabell Huntington Hospital

PGY2 Emergency Medicine: University of Illinois at Chicago

 Practice Interests:

Emergency medicine, toxicology, critical care

Adrienne Perotti, PharmD, BCPS, 

Clinical Pharmacy Specialist - Emergency Medicine

Rotations:

Adult/Pediatric Emergency Medicine

Education:

PharmD: University of Illinois-Chicago College of Pharmacy

Residency:

PGY1: University of Illinois Medical Center

PGY2-3 Emergency Medicine/Toxicology Fellowship: Florida/U.S. Virgin Islands Poison Information Center

 Practice Interests:

Trauma and Toxicology

Professional Organization Affiliation:

BCPS, ASHP

Internal Medicine

 

Jennifer Austin Szwak, PharmD, BCPS

Director, PGY2 Internal Medicine Residency Program

Clinical Pharmacy Specialist - Internal Medicine

Rotations:

Internal Medicine, Medical Writing

Education:

PharmD: Virginia Commonwealth University

DPLA: ASHP Pharmacy Leadership Academy

Residency:

PGY1: Emory Healthcare

PGY2 Internal Medicine: University of Chicago Medicine

 Practice Interests: 

Anticoagulation, COPD, kidney disease, glucose management, sickle cell disease, resident training and development 

Professional Organization Affiliation and Leadership:

  • ACCP – Adult Medicine PRN External Affairs Committee Chair, Research Committee Member

  • Vizient Pharmacy Research Committee – Vice Chair

  • Illinois Council of Health-System Pharmacists - Member

Publications:

  • Potter LM, Austin Szwak J. Long-term management of corticosteroids. ACCP Pharmacotherapy Self-Assessment Program 2019; Book 2:81-103.

  • Lee C, Austin Szwak J, Bastow S, McCarthy S. Impact of a nurse-driven diabetic ketoacidosis insulin infusion calculator on the rate of hypoglycemia. Journal of Patient Safety. Accepted Aug 2019.

  • Croy C, Buehrle K, Austin Szwak J. Clindamycin-associated acute generalized exanthematous pustulosis. J Clin Pharm Ther 2017; 42(4):499-501.

  • Shaw Phillips M, Abdelghany O, Johnston S, Rarus R, Austin-Szwak J, Kirkwood C. Navigating the Institutional Review Board (IRB) process for pharmacy-related research. Hosp Pharm 2017; 52:105-116.

  • Austin JH, Mieure KD, Weber LM, McCarthy BC. National characteristics of residency program interview processes. American Journal of Health-System Pharmacy 2015; 72(13):1085-6.

  • McCarthy BC, McConeghy KW, Austin JH. Re-measuring satisfaction among residents in ASHP-accredited pharmacy residency programs. American Journal of Health-System Pharmacy 2015; 72(12):997-9.

  • Austin JH, Bentley LE, Kolanczyk DM, Patel NP. Refractory proliferative lupus nephritis: an evidence-based review of pharmacotherapy. The journal of Pharmacy Technology 2013; 29(6):265-282.

  • Austin JH, Stearns CR, Winkler AM, Paciullo CP. Evaluation of chromogenic factor X activity levels to transition patients from argatroban to warfarin. Pharmacotherapy 2012; 32(6):493-501.

Academic and/or National Presentations:  

  • Implementation of a Psychological Debriefing in a 24-Hour, In-House Clinical On-call Program – March 2019, Missouri Society of Health-System Pharmacists & Illinois Council of Health-System Pharmacists Spring Meeting, Collinsville, IL

  • Creating a Culture of Resident Well-Being  October 2018 - ASHP National Pharmacy Preceptor Conference, Dallas, TX

  • UCM COPD Program: Medication Management July 2018 - COPD Foundation Readmissions Summit, Chicago, IL 

  • A Breath of Fresh Air: An Update in COPD Management April 2018 - Illinois Council of Health-System Pharmacists Spring Meeting, Peoria, IL

  • Data Management - Vizient Pharmacy Network Online Research Toolkit

  • Student Pharmacists: Expanding into New Frontiers August 2016 - National Pharmacy Preceptor Conference, Washington, DC

  • V Formation: Navigating and Enhancing Student Experiential Training and Research August 2014- National Pharmacy Preceptor Conference, Washington D.C.

  • Lupus Nephritis: Filtering the New Data April 2013- Illinois Council of Health-System Pharmacists/Missouri Society of Health-System Pharmacists Spring Meeting, St. Charles, MO

Current Research:

  • Impact of a Multidisciplinary Team on COPD Readmissions

  • Hypoglycemia Management in the Inpatient Setting

  • Resident Debriefing following On-Call Shifts

  • Clinical Knowledge Assessment in Residency Interviews

  • Prescribing Errors Intercepted by Pharmacists (multicenter study with Vizient)

  • Characterizing PGY2 IM Programs & Postgraduate Positions

Oncology

 

Sandeep Parsad, PharmD, BCOP

Director, PGY2 Oncology Pharmacy Residency

Assistant Pharmacy Director, Cancer & Investigational Drug Services

 

Rotations:

BMT/Cellular Therapy (CAR-T)

Gynecology Oncology

Introduction to Oncology Pharmacy Practice

Oncology Leadership

Personalized Therapeutics Clinic

Education:

PharmD: University of Illinois at Chicago

B.Pharm: Massachusetts College of Pharmacy and Health Sciences

Residency:

PGY1 & PGY2 Oncology: University of Illinois at Chicago

Practice Interests:

Hematologic malignancies, precision medicine, hematopoietic stem cell/bone marrow transplantation, oncology utilization management, administrative oncology

Jennifer Collins, PharmD

Coordinator, PGY2 Oncology Pharmacy Residency

Clinical Pharmacy Specialist - Hematology/Oncology

Rotations:

Inpatient BMT/Cellular Therapy, Outpatient BMT Clinic

Education:

PharmD: Belmont University, Nashville, TN

Residency:

PGY1 & PGY2 Oncology: University of Chicago Medicine

Practice Interests:

Bone Marrow Transplant, Cellular Therapy, Immunocompromised Infectious Disease

Professional Organization Affiliation and Leadership:

Hematology/Oncology Pharmacists Association (HOPA)

American Society for Transplantation and Cellular Therapy

Publications:

  • Collins JM et al. The impact of initiating posaconazole on tacrolimus pharmacokinetics in allogeneic stem cell transplantation. J Oncol Pharm Practice. 2019. DOI 10.1177/1078155219833440.

  • Collins JM, Flemin GF, and Christ TN. Comparison of the incidence of febrile neutropenia in obese and and normal weight breast cancer patients receiving myelosuppressive chemotherapy and prophylactic pegfilgrastim. J Oncol Pharm Practice. 2018. DOI 10.1177/1078155218776471.

Academic and/or National Presentations:  

  • Effect of Posaconazole on Tacrolimus Levels in Allogeneic Stem Cell Transplant Patients – May 2018 at the HOPA Annual Conference (Denver, CO)

  • QTc Monitoring in Patients on Prophylactic Azithromycin and Antidepressants – December 2017 at the ASHP Midyear Meeting (Orlando, FL)

  • Incidence of Febrile Neutropenia in Obese Breast Cancer Patients Receiving Pegfilgrastim – December 2016 at the ASHP Midyear Meeting (Las Vegas, NV)

  • Antimicrobial Stewardship: Considerations for Primary Care – December 2015 at the ASHP Midyear Meeting (New Orleans, LA)

Current Research:

  • Implementation of a Chemotherapy Restriction Program

  • Impact of the Implementation of a Pharmacist-Driven Tacrolimus Therapeutic Drug Monitoring Protocol

  • Tocilizumab versus Siltuximab for the Treatment of Cytokine Release Syndrome Associated with CAR-T Cell Therapy

Emily Dworkin, PharmD, BCOP

Coordinator, PGY2 Oncology Pharmacy Residency

Clinical Pharmacy Specialist - Hematology/Oncology

 

Rotations:

Malignant Hematology

Education:

PharmD: University of Iowa College of Pharmacy

Residency:

PGY1 and PGY2 in Oncology/Hematology: University of Wisconsin Health

Practice Interests:

Acute leukemias, treatment of leukemia in the adolescent and young adult population 

Professional Organization Affiliation and Leadership:

ASHP, HOPA

Lianna Serbas, PharmD, BCOP

Clinical Pharmacy Specialist - Oncology

 

Rotations:

GI Oncology Clinic; Supportive Care

Education:

PharmD: University of Illinois at Chicago College of Pharmacy

Residency:

PGY1: Captain James Lovell FHCC

PGY2 Oncology: VA San Diego Healthcare System

Practice Interests:

Gastrointestinal malignancies, supportive care 

Professional Organization Affiliation and Leadership:

Hematology/Oncology Pharmacists Association (HOPA)

Academic and/or National Presentations: 

Updates on the treatment of cancer-related venous thromboembolism (VTE) – September 2018 at Association of VA Hematology/Oncology (AVAHO) 2018 Annual Meeting

Pauline Lee, PharmD, BCOP

Clinical Pharmacy Specialist - Hematology/Oncology

Rotations:

Bone Marrow Transplant, Leukemia, Supportive Oncology, Medical Oncology

Education:

PharmD: Midwestern University Chicago College of Pharmacy

Residency:

PGY1 & PGY2 Oncology: University of Chicago Medicine

Practice Interests:

Benign and malignant hematology, palliatve care, bone marrow transplant

 

Infectious Disease

Natasha Pettit, PharmD, BCPS

Clinical Pharmacy Coordinator, Antimicrobial Stewardship/ID

Pharmacy Director, Antimicrobial Stewardship Program

Clinical Pharmacy Specialist - Infectious Diseases

 

Rotations:

Infectious Diseases (General), Antimicrobial Stewardship, Immunocompromised Infectious Diseases

Education:

PharmD: University of the Pacific

Residency:

PGY1: University of Michigan Health System

PGY2 Infectious Diseases: University of Michigan Health System

Practice Interests:

Managing MDR GN/GP infections, Antifungal pharmacotherapy, Antimicrobial stewardship

Professional Organization Affiliation and Leadership: IDSA, SHEA, SIDP, ACCP, ASHP, CLSI Antifungal susceptibility testing workgroup

Publications: See pubmed bibliography  

Academic and/or National Presentations:

  • Incorporating Antibiogram Data into Antimicrobial Stewardship Practices.  Illinois Fall SCACM Meeting, September 20, 2018.

  • ASHP Infectious Disease Board Review Course, Faculty.  CNS Infections. May, 2018.

  • American Physician Institute for Advanced Professional Studies, Infectious Diseases Board Review Course, Faculty.  Management of Antibiotic-Resistant Gram-Negative Infections.  January, 2018.

  • Antimicrobial Stewardship. Illinois Association of Physicians Assistants (IAPA) Fall CME.  September 16, 2017.

  • Enhancement of the Electronic Medical Record to Optimize Antimicrobial Stewardship Interventions. CLSI Educational Workshop.  June 24, 2017.

  • Society of Infectious Diseases Pharmacists (SIDP) Antimicrobial Stewardship Certificate Program, Faculty.  Lower Respiratory Tract Infections.  April, 2017.

Current Research:  Impact of candidemia ASP review on clinical outcomes, posaconazole TDM/dose adjustment protocol, Impact of rapid diagnostics (e.g. RBVP, GI-PCR) on antimicrobial utililzation/clinical outcomes

Cynthia Nguyen, PharmD, BCPS (AQ-ID)

Clinical Pharmacy Specialist - Infectious Diseases

 

Rotations:

Antimicrobial Stewardship, Immunocompromised Host Infectious Diseases, General Infectious Diseases

Education:

PharmD: University of California, San Francisco (UCSF)

Residency:

PGY1: University of California, San Francisco (UCSF)

PGY2: Infectious Diseases: University of Michigan Health System

Practice Interests:

Antimicrobial stewardship, Staphylococcus aureus bacteremia, quality improvement and patient safety

Publications 

  • Nguyen CT, Huang AM, Nagel JL. Improving antibiotic use through antimicrobial stewardship interventions upon discharge. Infect Control Hosp Epidemiol. 2019 Sept 16. doi: 10.1017/ice.2019.246 [Epub ahead of print]

  • Nguyen CT, Davis KA, Nisly S, et al. Treatment of Helicobacter pylori in Special Patient Populations. Pharmacotherapy. 2019 Aug 10. doi: 10.1002/phar.2318. [Epub ahead of print]

  • Nguyen CT, Reuter CM, Hudson T, et al. Evaluation of surgical site infection antibiotic prophylaxis among patients receiving antibiotics for active infection. J Hosp Infect. 2019 Jun 8. pii: S0195-6701(19)30232-4. doi: 10.1016/j.jhin.2019.06.001. [Epub ahead of print]

  • Nguyen CT, Davis KA. Evaluating the impact of peer comparison on vancomycin dose order verification among pharmacists. J Am Coll Clin Pharm. 2019 Apr;2:137-142.

  • Nguyen CT, Li J, Anders S, et al. Comparison of outcomes with vancomycin or metronidazole for mild-to-moderate Clostridium difficile associated diarrhea among solid organ transplant recipients: a retrospective cohort study. Transpl Infect Dis. 2018 Jun;20(3):e12867. 

  • Foolad F, Huang AM, Nguyen CT, et al. A multicentre stewardship initiative to decrease excessive duration of antibiotic therapy for the treatment of community-acquired pneumonia. J Antimicrob Chemother. 2018 May 1;73(5):1402-1407.

  • Nguyen CT, Nanfro J. Probable vancomycin-induced myasthenic crisis: a case report. J Antimicrob Chemother. 2018 Apr 1;73(4):1106-1108.

  • Nguyen CT, Li J, Occhipinti E, Hand J. Challenges in procalcitonin implementation in the real-world. Open Forum Infect Dis. 2018 Jan 15;5(2):ofy012.

  • Additional PubMed indexed publications: https://www.ncbi.nlm.nih.gov/myncbi/1JwcZJvR6iWsf6/bibliography/public/

Recent academic and/or national presentations: 

  • American Physician Institute for Advanced Professional Studies, Infectious Diseases Board Review Course, Faculty.  Management of Antibiotic-Resistant Gram-Positive Infections.  Chicago, IL. Jan 2018.

  • Louisiana Health-System Pharmacists (LSHP) Webinar. New Orleans, LA. May 2017.

  • Antimicrobial Stewardship: Focusing on Penicillin Allergy & Asymptomatic Bacteriuria. Louisiana Health-System Pharmacists (LSHP) Annual Meeting. New Orleans, LA. May 2016.

Current research: 

  • Impact of beta-lactam allergy labels on perioperative antimicrobial prophylaxis

Professional organization affiliation and leadership:

  • Society for Healthcare Epidemiology of America (SHEA)

    • Journal Club Committee 

    • Faculty, Prevention Course for Healthcare-Associated Infections Knowledge and Control

  • Society of Infectious Diseases Pharmacists (SIDP)

    • Chair, Bylaws and Nominations Committee

  • American College of Clinical Pharmacy (JACCP)

    • Infectious Diseases PRN Research Committee

    • IDSAP Certified Practice Reviewer

 

Solid Organ Transplant

Lisa Potter, PharmD, BCPS, FCCP, FAST

Director, PGY2 Solid Organ Transplant Pharmacy Residency

Clinical Coordinator - Organ Transplantation

 

Rotations:

Solid Organ Transplant - Liver

Solid Organ Transplant - Lung

Education:

PharmD: University of Nebraska Medical Center

Residency:

PGY1: Thomas Jefferson University Hospital

PGY2 Solid Organ Transplant: University of Utah Hospitals and Clinics

Practice Interests:

Liver transplantation, lung transplantation, transplant pharmacy practice management, medication access and affordability in the US healthcare system  

Professional Organization Affiliation and Leadership

  • American Society of Transplantation (AST): Board of Directors, Public Policy Committee, Investment Advisory Committee, and Transplant Community Taskforce

    • AST Audit Committee: Past Chair 

    • AST Financial Advisory Committee: Member 

    • AST Transplant Pharmacy Community of Practice: Past Chair 

  • International Pharmaceutical Federation (FIP), Hospital Pharmacy Section: Chair of Communications

  • American College of Clinical Pharmacy (ACCP): Member 

    • ​Content Matter Expert and Mentor Panel for the Solid Organ Transplant Board Certification Prep Course 

  • American Society of Health-System Pharmacists (ASHP): Member 

    • ​Content Matter Expert and Mentor Panel for the Solid Organ Transplant Board Certification Prep Course 

  • Illinois Council of Health-System Pharmacists: Member

 

Recent Publications (past 5 years)

  • Lyons P, Castillo J, Potter L, et al. Serum sickness after treatment with rabbit antithymocyte globulin in a heart transplant recipient with previous rabbit exposure. Transplant Proc 2015; 47(1): 198-200. 

  • Gabardi S, Asipenko N, Fleming J, Lor K, McDevitt-Potter L, et al. Evaluation of low- versus high-dose valganciclovir for prevention of cytomegalovirus disease in high-risk renal transplant recipients. Transplantation 2015; 99(7): 1499-505.

  • Petty LA, Qamar S, Ananthanarayanan V, Husain AN, Murks C, Potter L, et al.  Cardiac toxoplasmosis after heart transplantation diagnosed by endomyocardial biopsy.  Transpl Infect Dis 2015; 17(5): 719-22.  

  • Potter L, Tichy EM, Horwedel TA, et al.  Impact of the pharmacy practice model initiative on clinical pharmacy specialist practice: an alternative viewpoint.  Pharmacotherapy 2016; 36(11): e195-97.

  • Potter L, Maldonado AQ, Lentine KL, et al.  Transplant Recipients are Vulnerable Under the Medicare Part D Benefit.  Am J Transplant 2018; 18(6): 1502-9.  

  • Maldonado AQ, West-Thielke P, Dew MA, Peipert JD, Heldenbrand S, Kaiser TE, Chisholm-Burns M, Potter LM; AST Transplant Pharmacy Adherence Consortium (AST TPAC). Meeting Report: Consensus Recommendations for a Research Agenda to Address Immunosuppressant Non-Adherence in Organ Transplantation.  Clin Transplant 2018; 32(9): e13362.

  • Potter LM.  Are generic immunosuppressive drugs the solution for providing lifelong medication coverage to transplant recipients?  Clin J Am Soc Nephrol 2019; 14(3): 327-9. 

  • Potter L, Lushin EN, Hofmeyer B, et al.  Discharge medication procurement and education after kidney transplantation.  Clin Transplant 2019; 33(8): e13627. 

Recent Academic and/or National Presentations (past 5 years)

  • “CMS Survey: Requirements Regarding Transplant Pharmacy Services.” Clinical Practitioner and Researcher Network program; Illinois Council of Health-System Pharmacists. Chicago, IL. Mar 2015.

  • “Hoops, Gaps, and Approvals: Anticipating and Overcoming Medication Cost Barriers.”  American Transplant Congress.  American Society of Transplantation and the American Society of Transplant Surgeons; Philadelphia, PA.  May 2015. 

  • “The Drug Dealers: Messing with the Immune System.” American Transplant Congress.  American Society of Transplantation and the American Society of Transplant Surgeons; Philadelphia, PA.  May 2015.

  • “Non-Adherence: Why is it Still a Problem?”  Cutting Edge of Transplant.  American Society of Transplantation; Phoenix, AZ.  Feb 2016.

  • “Overcoming Financial Hurdles in the Post-Transplant Setting: Optimizing Insurance Coverage.”  American Transplant Congress.  American Society of Transplantation and the American Society of Transplant Surgeons; Boston, MA.  June 2016. 

  • “Financial Challenges of Transplant.”  ACCP Immunology/Transplantation Practice and Research Network Webinar.  Dec 2016.

  • “Making Sense of It All: Understanding the Regulatory Requirements for Pharmacists.”  American Transplant Congress.  American Society of Transplantation and the American Society of Transplant Surgeons; Chicago, IL.  Jun 2017. 

  • “Drug Interactions and Safety.”  AST Comprehensive Trainee Curriculum online modules.  Jul 2017.

  • “The 100-meter event: Maximizing Insurance and Discount Programs.”  Symposium on the Hurdles of Medication Costs.  Pharmaceutical Industry Practice and Research Network Focus Session.  American College of Clinical Pharmacy.  Phoenix, AZ.  Oct 2017

  • “No, the Risks and Costs of Novel Agents Outweigh Their Benefit: Con Counterpoint.”  Debate on the Role of Novel Agents in Managing Antibody-Mediated Rejection.  Immunology/Transplantation Practice and Research Network Focus Session.  Annual Meeting: American College of Clinical Pharmacy. Phoenix, AZ.  Oct 2017. 

  • “Transplant Regulatory Requirements.”  ACCP Immunology/Transplantation Practice and Research Network webinar.  May 2018.

  • “Efficacy of Immunosuppression and Impact of Sex.” American Transplant Congress. American Society of Transplantation and the American Society of Transplant Surgeons; Seattle, WA. May 2018. 

  • “The ABCs of Immunosuppression Billing in the Ambulatory Care Setting.” American Transplant Congress.  American Society of Transplantation and the American Society of Transplant Surgeons; Seattle, WA.  May 2018.

  • “Financial Concerns When Living With a Transplant or Considering Donation.”  2018 Transplant Games.  Transplant Games of America.  Salt Lake City, UT.  Aug 2018. 

  • “Prograf vs Astagraf XL vs Envarsus XR: Which Tacrolimus is Best?”  ITNS Transplant Nursing Symposium.  Chicago, IL; Sep 2018.

  •  “Tacro-what? How to Select the Right Product.”  Presenter; Clinical Pearls Session.  Midyear Clinical Meeting.  American Society of Health-System Pharmacists; Anaheim, CA.  Dec 2018. 

  • “Development of Clinic Transplant Pharmacist Services: Who, What, When, and Where.” AST/ASTS American Transplant Congress.  Boston, MA; Jun 2019.

  • “Pharmacy: Better Living Through Chemistry.”  AST/ASTS American Transplant Congress.  Boston, MA; Jun 2019.

           

Laura Lourenco, PharmD, BCPS

Residency Coordinator, PGY2 Solid Organ Transplant

Clinical Pharmacy Specialist – Organ Transplantation

 

Rotations:

Heart Transplant

Education:

PharmD: Massachusetts College of Pharmacy and Health Sciences

Residency:

PGY1: University of Illinois at Chicago

PGY2 Transplant: Barnes Jewish Hospital

Practice Interests:

          HIV in thoracic transplant, pharmacokinetics of immunosuppressants,       

          medication adherence

 

 

Brenna Kane, PharmD, BCPS

Clinical Pharmacy Specialist - Organ Transplantation

Rotations:

Solid Organ Transplant - kidney/pancreas

Education:

PharmD: North Dakota State University

Residency:

PGY1 & PGY2 Solid Organ Transplant: Hennepin County Medical Center

Practice Interests:

Kidney and pancreas transplant, solid organ transplant in HIV positive recipients, skin cancer after solid organ transplant, multidisciplinary education

 

Pediatrics

Deborah Bondi, PharmD, BCPS, BCPPS

Director, PGY2 Pediatrics Pharmacy Residency

Clinical Pharmacy Specialist - Neonatal Intensive Care

 

Rotations:

PGY1 Pediatric Selective (Neonatal ICU), PGY2 Pediatric Neonatal ICU, PGY2 Pediatric Nutrition

Education:

PharmD: University of Missouri - Kansas City

Residency:

PGY1 & PGY2 Pediatrics: University of Illinois at Chicago

Practice Interests:

Neonatology, prevention and treatment of the complications of prematurity

Professional Organization Affiliation and Leadership:

  •  ACCP Appointed Positions: Faculty for the Preparatory Review and Recertification Course - Updates in Therapeutics (2017-Present); Pediatric PRN Chair Elect (21019-2020); Certification Affairs Committee (2019-2020); Clinical Practice Affairs Committee (2018-2019); Organizational Affairs Committee (2017-18); Pediatric Standard Setting Panel (2016-18); Pediatric PRN Education Committee Chair (2016-17); Pediatric PRN Education Committtee Vice-Chair (2015-16); Certification Affairs Committee (2014-16); National Resident Advisory Committee (2011-13)

  • ACCP Volunteer Committees: Pediatric PRN Research Committee (2018-Present); Pediatric PRN Education Committee (2012-Present)

  • PPAG Volunteer Committees: Moderator at Annual Meeting (2017-Present); Education Committee (2013-Present)

  • UChicago Medicine Pharmacy Residency Committees: Preceptor Development Task Force (PDTF) Chair (2016-Present); Recruitment Committee Advisor (2017-Present); Public Relations Committee Advisor (2017-Present)

Publications:

  • Book Chapters:

    • Bondi DS. “Steroids in Bronchopulmonary Dysplasia.” PedSAP: Pediatric Pulmonary Disorders. American College of Clinical Pharmacy, 2019.

    • Bondi DS. “Pediatrics.” Updates in Therapeutics® 2019: Pharmacotherapy Preparatory Review and Recertification Course. American College of Clinical Pharmacy, 2019. Previous editions: 2018.

    • Bondi DS. “Congenital Infections.” PedSAP: Neonatal and Pediatric Sepsis. American College of Clinical Pharmacy, 2018.

    • Bondi DS, Ohler KH. “Chapter 71: Neonatal Medication Considerations.” Essential Guide to Clinical Neonatology. Ed. Jeanette D. Hoenig, Ed. Alison Chu, Ed. Joseph R. Hageman. Hauppauge: Nova Science Publishers, Inc., 2016. Print. ISBN: 978-1-53610-198-0.

  • Peer-Reviewed Publications:

    • Patel PD, Bhagat P, Bartlett AH, Bondi DS. Comparison of neonatal outcomes with the use cefotaxime versus ceftazidime in a neonatal intensive care unit. J Pediatr Pharmacol Ther. Accepted Sep 2019.

    • Shenk EE, Bondi DS, Pellerite MM, Sriram S. Evaluation of timing and dosing of caffeine citrate in preterm neonates for the prevention of bronchopulmonary dysplasia. J Pediatr Pharmacol Ther. 2018;23(2):139-145.

    • Bondi DS, Ohler KH. Vasopressin and hemodynamic effects on the neonate. Neoreviews. 2017;18(8):e460-e471.

    • Saseen JS, Ripley TL, Bondi DS, Burke JM, Cohen LJ, et al. ACCP Guideline: ACCP clinical pharmacist competencies. Pharmacotherapy. 2017;37(5):630-636.

    • Welsh K, Bondi DS, Frost B. Probiotics for prevention of necrotizing enterocolitis in neonates. Neoreviews. 2016;17(7):e377-e385.

    • Bondi DS, Khan OA, Hageman JR. Maternal selective serotonin reuptake inhibitor use and neurologic effects on the neonate. Neoreviews. 2016;17(7):e356-e366.

    • Raithel DS, Ohler KH, Porto I, Bicknese AR, Kraus DM. Morphine: an effective abortive therapy for pediatric paroxysmal sympathetic hyperactivity after hypoxic brain injury. J Pediatr Pharmacol Ther. 2015;20(4):335-340.

Academic and/or National Presentations:

  • February 2018 - present (recurs annually): “Pediatrics.” American College of Clinical Pharmacy Updates in Therapeutics®: Pharmacotherapy Preparatory Review and Recertification Course: Rotating Locations.

  • April 2018: “Don’t Be So Shocked! Updates from the American College of Critical Care Medicine on the Management of Pediatric and Neonatal Shock.” Pediatric Pharmacy Advocacy Group Annual Meeting: Salt Lake City, UT

  • May 2013: “Neonatal Indomethacin for the Prevention of Intraventricular Hemorrhage: A Study of Plasma Concentrations, Pharmacogenomic Factors, and Outcomes.” Pediatric Pharmacy Advocacy Group Annual Meeting: Indianapolis, IN.

Current Research:

  • Rodriguez I, Bondi D, Singh J, Nelson K, Shah P. Comparison between acetaminophen monotherapy, indomethacin monotherapy, and combination indomethacin with acetaminophen for closure of the patent ductus arteriosus in preterm neonates

  • Pan I, Shah P, Kelly K, Singh J, Bondi D. Comparison of neonatal outcomes with and without prophylaxis with indomethacin in premature neonates.

  • Bondi D, Shah P, Hussain W, Bartlett A, Knoebel R, Morgan S, Mosakowski S, Orr RJ, Parker B, Patel Y, Singh J, Schreiber M. Inhaled nitric oxide stewardship in the neonatal intensive care unit.

  • Weaver K, Bondi D, Shah P, Bhagat P. Evaluation of appropriateness and cost-savings of pharmacist-driven palivizumab ordering. 

Allison Nelson, PharmD, BCPS, BCPPS

Coordinator- PGY2 Pediatrics Pharmacy Residency

Clinical Pharmacist Specialist - Pediatric Infectious Diseases

Associate for Pediatrics, Antimicrobial Stewardship Program

Rotations:

Pediatric Infectious Diseases

Education:

PharmD: University of Missouri - Kansas City

Residency:

PGY1: University of Chicago Medicine

PGY2 Pediatrics: University of Chicago Medicine

Practice Interests:

Pediatric congenital heart disease, pediatric septic shock

Professional Organization Affiliation and Leadership

  • PPAG: 2017  &  2018  Annual  Meeting  Committee , Critical  Care  Sig  Member , RPD  Sig  Member

  • Illinois Council for Health System Pharmacists

  • American  College  of  Clinical  Pharmacy: Pediatrics  PRN  Member

  • American  Society  of  Health  System  Pharmacists 

Publications

  • Nelson AL. Pharmacology for Pediatric Patients. In: Pediatric Critical Care: A Primer for All Clinicians. Kane J, Wolfson R, Berger S and J Hageman ed., New York: Nova Science Publishers, Inc; 2019; 593-601.  

  • Kaulitz  R,  Thompson  AL  and  G  Ziemer.  Critical  care  in  pediatric  cardiac  surgery.  In:  Cardiac  Surgery:  Operations  on  the  heart  and  great  vessels  in  adults  and  children.  Ziemer  G  and  A  Haverich  ed.,  Berlin:  Springer;  2017;  251-290. 

  • Thompson  AL,  Smith  AJ.  Clopidogrel  plus  proton  pump  inhibitors:  a  therapeutic  dilemma.  Clinical  Pharmacist  2010;2:137-40.

Academic and/or National Presentations

  • August 2019

    • “From Guidelines to the Bedside: Pediatric Sepsis Bundles and Trigger Tools.” Co-Presenter with Priti Jani, MD, MPH. Chicagoland Critical Care Conference: Chicago, IL.

  • March 2015, 2017 & 2018:

    • Pediatric  Seizure  Management Lecture, PHAR 6323 DMTM II, Chicago State University School of Pharmacy

  • April 2017:

    • Pediatric  Critical  Care  Lecture,  Critical  Care  Pharmacotherapy  Elective,  Chicago  State  University  School  of  Pharmacy

  • March 2017:

    • Applied  Pediatric  Principles  Lecture,  PHAR  6323  DMTM  II,  Chicago  State  University  School  of  Pharmacy

Reggie King, PharmD, BCOP

Clinical Pharmacy Specialist - Pediatric Hematology/Oncology

Rotations:

Pediatric Oncology

Education:

PharmD: University of Michigan

Residency:

PGY1: Thomas Jefferson University Hospital

PGY2 Oncology: University of California, San Francisco

Practice Interests:

Inpatient/outpatient pediatric hematology/oncology, clinical trials, investigational drug therapy

Palak Bhagat, PharmD, BCPS

Clinical Pharmacy Specialist - Pediatric Infectious Diseases

Rotations:

Pediatric Infectious Diseases

Education:

PharmD: University of Illinois at Chicago

Residency:

PGY1: Lutheran General Hospital 

PGY2 Pediatrics: University of Illinois at Chicago 

Practice Interests:

Pediatrics, pediatric infectious diseases

Pooja Shah, PharmD

Clinical Pharmacy Specialist - Neonatal Intensive Care

 

Rotations:

Neonatal Intensive Care Unit

Education:

PharmD: Butler University

Residency:

PGY1- Northshore University Health System

Practice Interests:

Neonatology

 

Emily Belarski, PharmD

Clinical Pharmacy Specialist

 

Rotations:

General Pediatrics 

Education:

PharmD: University of Michigan College of Pharmacy

Residency:

PGY1: Indiana University Health (Indianapolis, IN) 
PGY2: Pediatrics: Riley Hospital for Children at IU Health (Indianapolis, I

Practice Interests:

HIV, cystic fibrosis, asthma, ID, neurology

Professional Organization Affiliation and Leadership

  • ASHP (2014 – Present): New Practitioner Membership Advisory Group, ASHP Foundation Donor Retention Committee

  • PPAG (2017 – Present)

Alexandria Hissong, PharmD

Clinical Pharmacy Specialist - Pediatric Intensive Care

 

Rotations:

Pediatric Intensive Care Unit

Education:

PharmD: Butler University 

Residency:

PGY1: Ascension Indiana – St. Vincent Indianapolis Hospital
PGY2 Pediatrics: Ascension Indiana – Peyton Manning Children’s Hospita

Practice Interests:

ECMO, status asthmaticus, ARDS

Specialty

Huda-Marie Kandah, PharmD

Director- PGY2 Health Systems Administration Specialty Pharmacy  Residency

Clinical Manager - Specialty Pharmacy

Rotations:

 Specialty Management

Education:

PharmD: Midwestern University Chicago College of Pharmacy

Residency:

PGY1: Rush University Medical Center

 

Christy Gorbach, PharmD, MS

Pharmacy Manger, DCAM Outpatient Pharmacy & Transitions in Care

Rotations:

 Retail Pharmacy Management

Education:

PharmD: Purdue University School of Pharmacy

Residency:

PGY1/PGY2 Health System Administration: Houston Methodist

 Practice Interests:

          Leadership, Ambulatory Pharmacy, Transitions in Care

Shannon Rotolo, PharmD, BCPS

Director, PGY1 Non-Traditional Pharmacy Residency

Clinical Pharmacy Specialist – General Pediatrics

 

Rotations:

Specialty Pharmacy (focus on pulmonology and pediatrics)

Education:

PharmD: University of Buffalo

Residency:

PGY1: University of Rochester, Golisano Children’s Hospital

Practice Interests:

Cystic fibrosis, asthma, pediatric lupus

Publications:

  • Muirhead C, Palmore W, Condren M, Rotolo SM, Pettit RS, Gill M, Phan H. Survey: Evaluation, Documentation, and Education about Cannabis Use in Cystic Fibrosis. Pediatric Pulmonology 2019; 54(S2):379.

  • Rotolo SM, Hegde, S. Mepolizumab in Pediatric Patients with Severe Eosinophilic Asthma: A Single Center Experience. American Journal of Respiratory and Critical Care Medicine. 2019; 199: A7473.

  • McEwen CQ, Rotolo SM. Oral Glucose Tolerance Testing: A Quality Improvement Initiative to Increase Adherence. Pediatric Pulmonology 2018; 53(S2):449.

  • Rotolo SM. Collins J. Dowell M. QTc Monitoring in Patients Receiving Prophylactic Azithromycin with Concomitant Antidepressants. Pediatric Pulmonology 2018; 53(S2):330.

  • Rotolo SM. Janes P. Anderson K. Dowell M. Proton Pump Inhibitor Utilization and Adverse Effects in CF Patients at a Large Academic Medical Center. Pediatric Pulmonology 2017; 52(47):S463-S464.

Academic and/or National Presentations:

  • "Learning to Pivot: How to move forward after going unmatched for residency."  Presented to pharmacists and pharmacy students.  Pediatric Pharmacy Advocacy Group, Fall Meeting; September 2019.

Shivani Patel, PharmD, BCPS

Clinical Pharmacy Specialist - Gastroenterology/Rheumatology

Rotations:

Specialty Pharmacy

Education:

PharmD: University of Oklahoma Health Sciences Center

Residency:

PGY1: University of Chicago Medicine

 Practice Interests:

Hilary Sheridan, PharmD 

Clinical Pharmacist

Rotations:

Specialty Pharmacy- Infusion Center

Education:

PharmD: Midwestern University Chicago College of Pharmacy

Residency:

PGY1: University of Minnesota Medical Center

 Practice Interests:

 General Medicine, Neurology, Gastroenterology, Rheumatology

Archariya Puangampa, PharmD, BCPS 

Clinical Pharmacist - Gastroenterology

Rotations:

Specialty Pharmacy

Education:

PharmD: University of Illinois at Chicago

Residency:

PGY1: University of Chicago Medicine

 Practice Interests:

 Adult and pediatric gastroenterology, Inflammatory bowel disease

Monika Lach, PharmD, BCPS

Clinical Coordinator, Specialty Pharmacy

Rotations:

Specialty Pharmacy, Hematology/Oncology, Specialty Pharmacy Management

Education:

PharmD: University of Colorado

Residency:

PGY1/2 Health System Pharmacy Administration: University of Chicago Medicine

 Practice Interests:

 Hematology/Oncology, Biomedical Informatics, Health Outcomes

Presley Blount, PharmD

Clinical Pharmacy Manager, Ambulatory Pharmacy 

Rotations:

Ambulatory Clinical Pharmacy Management

Education:

PharmD: Northeast Ohio Medical University

Residency:

PGY1: Summa Health System

PGY2 Health-System Pharmacy Administration: University of Illinois at Chicago

 Practice Interests:

 Ambulatory Pharmacy, Clinical Management, Medication Access 

Professional Organization Affiliation and Leadership:

 American Society of Health-System Pharmacists (ASHP), Illinois Council of Health-System Pharmacists (ICHP)

Nadiyah Chaudhary, PharmD, BCPS

Clinical Pharmacist Specialist-Specialty Pharmacy

Rotations:

Specialty Pharmacy

Education:

PharmD: University of Illinois at Chicago

Residency:

PGY1: CPS/Mercy Hospital and Medical Center

 Practice Interests:

 Women's health, fertility, endocrinology

Maitri Patel, PharmD

Clinical Pharmacist Specialist-Specialty Pharmacy

Rotations:

Specialty Pharmacy – Rheumatology, Dermatology

Education:

PharmD: University of Kansas School of Pharmacy

Residency:

PGY1: UC San Diego Health 

 Professional organization affiliation:

 ASHP, ACCP

 Practice Interests:

Rheumatology, Dermatology, Cardiology

Recent academic and/or national presentations:

  • The Dawn of Interprofessional Medicine: Evidence for Interactive Simulations with Medication Reconciliation

  • Crucial Conversations and Conflict Resolutions

  • Medical Management of Sexual Assault Survivors at an Academic Medical Center after Institutional Guideline Implementation

 

Paul Djuricich, PharmD, AAHIV

Clinical Pharmacist Specialist - Infectious Disease & HIV

Rotations:

HIV - Outpatient Parenteral Antibiotic Monitoring

Education:

PharmD: Purdue University

 Practice Interests:

HIV treatment; pre exposure prophylaxis

Ambulatory  Services

Margaret Allison, PharmD, BCACP

Clinical Pharmacy Specialist- Endocrinology

Rotations:

Ambulatory Care

Education:

The University of Illinois at Chicago

Residency:

PGY1- The University of Chicago Medicine; PGY2 Ambulatory Care-Indiana University Health

Practice Interests:

Anticoagulation, Diabetes, Transitions of Care

 

Emma Carroll, PharmD, BCOP

Rotations:

Breast and genitourinary medical oncology ambulatory care

Education:

BS in Biology: Roosevelt University

PharmD: University of Illinois at Chicago

Residency:

PGY1: Universtiy of Utah

PGY2 Oncology: Hunstman Cancer Institute, University of Utah

 Practice Interests:

 Breast and genitourinary medical oncology, immunotherapy related toxicities, and precision medicine in oncology 

Meds to Beds

Traci Hennessy, PharmD, BCPS

Clinical Pharmacist - Meds2Beds

Rotations:

Meds2Beds

Education:

PharmD: University of California, San Diego

Residency:

PGY1: University of Chicago Medicine

 Practice Interests:

Ambulatory care, anticoagulation, pharmacokinetics, transitions of care

Peter J. Kaiser, PharmD, BCPS

Clinical Pharmacist Specialist- Meds2Beds

Rotations:

Ambulatory Care/Transitions of Care (Meds2Beds)

Education:

PharmD: University of Maryland School of Pharmacy

Residency:

PGY1: University of Chicago Medicine

Practice Interests:

Ambulatory Care, Transitions of Care

Cody Chan, PharmD

Clinical Pharmacist - Meds2Beds

 

Rotations:

Meds2Beds, Transition of Care

Education:

PharmD: Chicago State University

Residency:

PGY1: Spectrum Health, Grand Rapids, MI

 Practice Interests:

Pediatrics

 

Clinical Pharmacists

Angela Kerins, PharmD, BCPS

Clinical Pharmacist

Rotations:

Hospitalist, Cardiology, Pharmacy Practice Experience

Education:

PharmD: University of Illinois at Chicago

Residency:

PGY1: University of Chicago Medicine

 Practice Interests:

General medicine, hematology/oncology

Satoru Ito, PharmD, BCPS

Clinical Pharmacy Specialist 

Rotations:

Med Surg/Trauma

Education:

PharmD: University of Arizona College of Pharmacy

Residency:

PGY1: University of Chicago Medical Center

Practice Interests:

Surgery, Pain management, Cardiology

Jaleesa Myers, PharmD

Clinical Pharmacy Specialist 

Rotations:

Cardiology

Education:

PharmD: Purdue University College of Pharmacy

Residency:

PGY1: Parkview Regional Medical Center

Practice Interests:

Cardiology, Anticoagulation, General Medicine

Matt Zhang, PharmD

Clinical Pharmacy Specialist 

Rotations:

Supportive care/ chemotherapy service

Education:

PharmD: University of Illinois at Chicago

Residency:

PGY1: Community Healthcare System- Community Hospital

Practice Interests:

Supportive oncology, palliative care, oncology stewardship

Professional organization affiliation and leadership:

HOPA, ASCO, NCCN

Recent Publications:

  • Zhang, J. (2018, February) Biosimilar formulary evaluation: a pharmacist’s guide. HOPA news, 15(4).

Recent academic and/or national presentations:

  • Zhang, J, Chantarapanont, S. Pharmacy- driven chemotherapy stewardship in a community hospital setting. Presentation presented at ASHP Midyear Clinical Meeting. Anaheim, CA; 2018 Dec.

Current Research​:

  • Optimizing oncology stewardship, Improvement in patient quality of care in relapse and refractory cancer patients 

Scott Lozano, PharmD, BCPS, BCNPS

Clinical Pharmacist - Nutrition Support

Rotations:

Nutrition Support

Education:

PharmD: University of Illinois at Chicago

Practice Interests:

Nutrition, IBD, kinetics, critical care